Opiant Pharmaceuticals Inc
(OPNT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2017 | 09-2017 | 07-2017 | 06-2017 | 04-2017 | |
| Sales | 22 | 22 | 0 | 3,772 | 18 |
| Gross Profit | 22 | 22 | N/A | 3,772 | 18 |
| Operating Expenses | 5,628 | 2,866 | 0 | 3,561 | 3,184 |
| Operating Income | -5,606 | -2,844 | N/A | 211 | -3,166 |
| Other Income | -27 | -15 | 0 | 28 | 36 |
| Pre-tax Income | -5,633 | -2,859 | 0 | 239 | -3,130 |
| Income Tax | N/A | 550 | N/A | N/A | N/A |
| Net Income Continuous | -5,633 | -3,409 | N/A | 239 | -3,130 |
| Net Income | $-5,633 | $-3,409 | $N/A | $239 | $-3,130 |
| EPS Basic Total Ops | -2.77 | -1.68 | N/A | 0.12 | -1.55 |
| EPS Basic Continuous Ops | -2.77 | -1.68 | N/A | 0.12 | -1.55 |
| EPS Diluted Total Ops | -2.77 | -1.68 | N/A | 0.11 | -1.55 |
| EPS Diluted Continuous Ops | -2.77 | -1.68 | N/A | 0.11 | -1.55 |
| EBITDA(a) | $-5,604 | $-2,843 | $N/A | $213 | $-3,164 |